When drugs in the same controlled substance schedule differ in real-world abuse, should they be differentiated in labeling?

Medicine & Life Sciences

• Controlled Substances 100%
• Appointments and Schedules 53%
• Public Health 31%
• Pharmaceutical Preparations 27%
• Substance-Related Disorders 19%
• Drug Labeling 15%
• Prescription Drugs 12%
• Marketing 11%
• Attention Deficit Disorder with Hyperactivity 11%
• United States Food and Drug Administration 10%
• Global Health 10%
• Drug Development 10%
• Opioid Analgesics 9%
• Therapeutic Uses 9%
• Decision Making 8%
• Motivation 8%
• Communication 8%
• Costs and Cost Analysis 6%
• Therapeutics 1%

Chemical Compounds

• Controlled Substance 79%
• Drug 34%
• Prescription Drug 11%
• Analeptic Agent 8%
• Communication 5%
• Disorder 5%